Double-blind placebo controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.

Authors: Shahin Akhondzadeh, Jalil Fallah, Mohammad-Reza Mohammadi, Reza Imani, Mohammad Mohammadi, Bahman Salehi, Ahmad Ghanizadeh, Maedeh Raznahan, Soodeh Mohebbi-Rasa, Shams-Ali Rezazadeh, Saeedeh Forghani
Title: Double-blind placebo controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism.
Journal: Progress in Neuro-Psychopharmacology and Biological Psychiatry
Year: 2010
Volume: 34
Issue: 1
Page(s): pp. 32-36
Abstract Link: Read Abstract (New Window)
Publication Format: Journal Article
Efficacy Study/Review: Yes
Scientific Validity: Placebo, Peer-Reviewed, Double Blind, Controlled Trial
Keywords: Vasodilator, Antipsychotics, Atypical, Autism, Autistic Disorder, Challenging / Disruptive Behaviour, Child/Children, Compliance/On-Task, Hyperactivity, Inappropriate Speech / Vocalisation, Interaction/Withdrawl, Intervention, Irritability, Lethargy, Medication, Pentoxifylline, Pre-School / Toddlers, Primary / Elementary School Age, Restricted, Repetitive Patterns of Behaviour, Interests, or Activities, Risperidone, Social Skills, Stereotypy

Rate This Page